MPM Oncology Impact Management as of Dec. 31, 2020
Portfolio Holdings for MPM Oncology Impact Management
MPM Oncology Impact Management holds 16 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| TCR2 Therapeutics Common | 17.7 | $104M | 3.4M | 30.93 | |
| Repare Therapeutics Common (RPTX) | 13.9 | $82M | 2.4M | 34.30 | |
| iTeos Therapeutics Common (ITOS) | 13.5 | $80M | 2.4M | 33.82 | |
| Oncorus Common | 13.1 | $77M | 2.4M | 32.33 | |
| Harpoon Therapeutics Common | 11.0 | $65M | 3.9M | 16.61 | |
| Turning Point Therapeutics Common | 6.4 | $38M | 309k | 121.85 | |
| Epizyme Common | 5.3 | $31M | 2.9M | 10.86 | |
| MEI Pharma Common | 4.5 | $27M | 10M | 2.64 | |
| G1 Therapeutics Common | 4.4 | $26M | 1.4M | 17.99 | |
| ADC Therapeutics Common (ADCT) | 2.9 | $17M | 540k | 32.01 | |
| YmAbs Therapeutics Common (YMAB) | 2.8 | $17M | 337k | 49.51 | |
| Merus Common (MRUS) | 2.1 | $12M | 701k | 17.53 | |
| Intellia Therapeutics Common (NTLA) | 1.2 | $7.0M | 128k | 54.40 | |
| Avrobio Common (AVRO) | 0.9 | $5.1M | 364k | 13.94 | |
| Black Diamond Therapeutcs Common (BDTX) | 0.2 | $1.4M | 44k | 32.05 | |
| Autolus Therapeutics Common (AUTL) | 0.1 | $355k | 40k | 8.93 |
